Rethinking latent TB? Think again

Rethinking latent TB? Think again

Saved in:

Bibliographic Details
Main Authors:	R.E. Chaisson, P.C. Hopewell
Format:	Article
Language:	English
Published:	International Union Against Tuberculosis and Lung Disease (The Union) 2024-08-01
Series:	IJTLD Open
Subjects:	tb infection tbi tuberculin skin testing interferon-gamma release assay hiv
Online Access:	https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000008/art00001
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

C-Tb Skin Test: A Step Toward Tuberculosis Eradication
by: Harshini T Reddy, et al.
Published: (2024-05-01)

HIV and diabetes impair M. tuberculosis-specific interferon-gamma responses on QuantiFERON-TB Gold Plus testing
by: J.S. Zifodya, et al.
Published: (2024-05-01)

Evaluation of three novel antigens and costimulatory agents for improvement of M. Tuberculosis specific interferon gamma release assays
by: Sandra Schwarzlose-Schwarck, et al.
Published: (2025-02-01)

Diagnostic value of interferon-γ release assay in patients with COPD complicated with pulmonary tuberculosis
by: Yanxiao Rong, et al.
Published: (2025-01-01)

3HP preventive treatment among children and adolescents with HIV and child household contacts of TB patients
by: A. Kinikar, et al.
Published: (2024-09-01)

Modeling TB and HIV co-infections
by: Lih-Ing W. Roeger, et al.
Published: (2009-08-01)

Innovations in TB Screening and Preventive Therapy Services for PLHIV in Yogyakarta City, Indonesia
by: Dani Catrianiningsih, et al.
Published: (2025-01-01)

Experimental use of mycobacterial antigens in tuberculin skin test on water buffalo
by: Alessandra Martucciello, et al.
Published: (2023-11-01)

Acceptability of levofloxacin dispersible and non-dispersible tablet formulations in children receiving TB preventive treatment
by: D. T. Wademan, et al.
Published: (2024-02-01)

Three months of weekly rifapentine plus isoniazid for TB prevention among people with HIV
by: R. Borse, et al.
Published: (2024-09-01)

Mathematical analysis of the transmission dynamics of HIV/TB coinfection in the presence of treatment
by: Oluwaseun Sharomi, et al.
Published: (2007-12-01)

Applicability of TB-LAMP test for diagnosis of pulmonary TB among HIV-positive individuals
by: B. Muriithi, et al.
Published: (2025-01-01)

Assessment tuberculin skin test specificity in water buffalo using five different antigens
by: Alessandra Martucciello, et al.
Published: (2023-11-01)

Factors that shape the integration of HIV and TB services in Zomba District, Malawi
by: Alex F. Maseko, et al.
Published: (2025-02-01)

Heightened expression of type I interferon signaling genes in CD4+ T cells from acutely HIV-1–infected women is associated with lower viral loads
by: Elina El-Badry, et al.
Published: (2025-01-01)

Underestimated latent tuberculosis infection burden among school contacts in China: a cross-sectional study
by: Jin Yin, et al.
Published: (2025-01-01)

Children and providers’ perspectives on once-weekly rifapentine and isoniazid TB preventive therapy
by: A.J. Marthinus, et al.
Published: (2025-01-01)

Prevalence of TB-related symptoms and self-reported disability among adult TB survivors
by: A.K. McDonald, et al.
Published: (2024-12-01)

Commitment, partnerships and operational research: three priorities for 11 EMR countries to achieve TB elimination
by: M. van den Boom, et al.
Published: (2024-01-01)

Sputum availability and quality in country-level TB prevalence surveys
by: P. Papadopoulou, et al.
Published: (2024-11-01)

TB prevention activities in the WHO European Region
by: A. Matteelli, et al.
Published: (2024-08-01)

Comparative performance of tuberculin and defined-antigen cocktails for detecting bovine tuberculosis in BCG-vaccinated cattle in natural settings
by: Abebe Fromsa, et al.
Published: (2025-02-01)

Candidate approaches for predicting vitiligo recurrence: an effective model and biomarkers
by: Binhao Liu, et al.
Published: (2025-02-01)

Pentoxifylline Prevents Autoimmune MediatedInflammation in Low Dose Streptozotocin InducedDiabetes
by: Stanislava D. Sto&#353;i&#263;-Gruji&#269;i&#263;, et al.
Published: (2001-01-01)

The combined therapy of chronic hepatitis with pegilated interferon <i>a</i>-2а and ribavirin in patients with HIV-infection and patients with HCV monoinfection
by: N. D. Yuschuk, et al.
Published: (2009-02-01)

Mapping TB incidence across districts in Uganda to inform health program activities
by: N.J. Henry, et al.
Published: (2024-05-01)

Time to be seen and heard: Including children’s and adolescents’ voices in the South African TB response
by: C Goslett, et al.
Published: (2024-07-01)

A survey of the effectiveness of centralized consilia in providing advice on drug-resistant TB
by: A. Vasquez, et al.
Published: (2024-07-01)

The impact of the war in Ukraine on the prevalence of MDR/RR-TB in Poland
by: A. Nowinski, et al.
Published: (2025-01-01)

Progress in programmatic management of drug-resistant TB, WHO Eastern Mediterranean Region, 2018-2023
by: K. Bennani, et al.
Published: (2024-09-01)

Updated treatment guidelines for drug-resistant TB: how safe are clofazimine-based regimens?
by: E. Pontali, et al.
Published: (2024-11-01)

Comparative monocyte and T cell responses in DENV-exposed subjects from South-East Asia and DENV-naïve residents in Taiwan
by: Sheng-Hsuan Wang, et al.
Published: (2025-02-01)

Diagnosis of tuberculosis in buffaloes in Argentina: intradermoreaction, compatible lesions and bacteriological culture
by: Emilia Irina Martínez, et al.
Published: (2023-11-01)

Delay of innate immune responses following influenza B virus infection affects the development of a robust antibody response in ferrets
by: Thomas Rowe, et al.
Published: (2025-02-01)

TB drug susceptibility testing in high fluoroquinolone resistance settings
by: F. Saluzzo, et al.
Published: (2024-05-01)

A 10-year review of isoniazid-resistant TB management in Uzbekistan 2009-2020
by: M.L. Rekart, et al.
Published: (2024-07-01)

Severe outcomes among adults with TB during COVID-19
by: T. Jacobs, et al.
Published: (2024-07-01)

More is needed to end TB: commentary on the United Nations High-Level Meeting on TB
by: G. B. Migliori, et al.
Published: (2024-01-01)

Second-line drug-resistant TB and associated risk factors in Karakalpakstan, Uzbekistan
by: S. Moe, et al.
Published: (2024-09-01)

Genetic and peripheral biomarkers of comorbid posttraumatic stress disorder and traumatic brain injury: a systematic review
by: Kiriana Cowansage, et al.
Published: (2025-01-01)